相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Controversies in Ulcerative Colitis: A Survey Comparing Decision Making of Experts Versus Community Gastroenterologists
Brennan M. R. Spiegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Cost-Effectiveness of 5-Aminosalicylic Acid Therapy for Maintenance of Remission in Ulcerative Colitis
Eugene F. Yen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid
Carmine Stolfi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine
Thomas Ullman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
Jonathan P. Terdiman et al.
INFLAMMATORY BOWEL DISEASES (2007)
5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint
M. Gloria Luciani et al.
GASTROENTEROLOGY (2007)
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death
Daniele Fina et al.
EUROPEAN JOURNAL OF CANCER (2006)
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study
Fernando S. Velayos et al.
GASTROENTEROLOGY (2006)
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells
G Monteleone et al.
CELL DEATH AND DIFFERENTIATION (2006)
Chemoprevention: Risk reduction with medical therapy of inflammatory bowel disease
Erick P. Chan et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2006)
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
TP van Staa et al.
GUT (2005)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis
PDR Higgins et al.
GUT (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
SH Itzkowitz et al.
GASTROENTEROLOGY (2004)
Medicare cost in matched hospice and non-hospice cohorts
B Pyenson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Long-term Risk of Cancer in Ulcerative Colitis: A Population-Based Cohort Study From Copenhagen County
Karen V. Winther et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
A Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients
H Ikeuchi et al.
DIGESTIVE SURGERY (2004)
Mortality in inflammatory bowel disease: A population-based cohort study
T Card et al.
GASTROENTEROLOGY (2003)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells
A Reinacher-Schick et al.
CARCINOGENESIS (2003)
Colorectal cancer screening and surveillance: Clinical guidelines and rationale - Update based on new evidence
S Winawer et al.
GASTROENTEROLOGY (2003)
Survival and cause-specific mortality in ulcerative colitis: Follow-up of a population-based cohort in Copenhagen county
KV Winther et al.
GASTROENTEROLOGY (2003)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine - Results from a 20-year surveillance study
BU Lindberg et al.
DISEASES OF THE COLON & RECTUM (2001)
5-aminosalicylic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer
WA Brown et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
A decision analysis of surveillance for colorectal cancer in ulcerative colitis
F Delcò et al.
GUT (2000)
Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel
A Reinacher-Schick et al.
ENDOSCOPY (2000)
Risk factors for morbidity and mortality after colectomy for colon cancer
WE Longo et al.
DISEASES OF THE COLON & RECTUM (2000)
分享论文
